UPDATE: Onyx Pharmaceuticals (ONXX) Sees Activity as FDA Briefing Docs Posted
Tweet Send to a FriendGet Alerts ONXX Hot Sheet
Trade ONXX Now!
(Updated - June 18, 2012 8:22 AM EDT)
Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) is seeing volatility as FDA briefing documents have been posted. Link
Shares last traded down fractionally to $45.28, versus Friday's close of $45.98.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) is seeing volatility as FDA briefing documents have been posted. Link
Shares last traded down fractionally to $45.28, versus Friday's close of $45.98.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Amarin's (AMRN) Vascepa Not in FDA Orange Book for April
- UPDATE: Tesoro Corporation (TSO) May Take Ownership of BP Carson in Early June - Reuters
- Berkshire Hathaway (BRK-A) Cut to 'AA' From 'AA+' by S&P
Create E-mail Alert Related Categories
FDA, Trader Talk
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
